An Open Label, Randomized, Single Dose, Two-Way Crossover Bioequivalence Study Comparing A Pediatric Appropriate Formulation To A 10 Mg Commercial Atorvastatin Calcium Tablet Formulation In Healthy Subjects.

Trial Profile

An Open Label, Randomized, Single Dose, Two-Way Crossover Bioequivalence Study Comparing A Pediatric Appropriate Formulation To A 10 Mg Commercial Atorvastatin Calcium Tablet Formulation In Healthy Subjects.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 21 Dec 2008

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Lipid metabolism disorders
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 21 Dec 2008 Actual initiation date (Nov 2008) added as reported by ClinicalTrials.gov.
    • 20 Nov 2008 Status changed from not yet recruiting to recruiting, as reported in ClinicalTrilas.gov record.
    • 14 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top